These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1576056)

  • 41. Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease.
    Aykanat A; Yavuz T; Özalkaya E; Topçuoğlu S; Ovalı F; Karatekin G
    Pediatr Cardiol; 2016 Jan; 37(1):131-4. PubMed ID: 26260095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of prostaglandin E1 metabolites on the induction of arterial thromboresistance.
    Sinzinger H; Neumann I; O'Grady J; Rogatti W; Peskar BA
    Prostaglandins Other Lipid Mediat; 1998 Apr; 55(5-6):265-75. PubMed ID: 9653766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndrome.
    Cox JW; Andreadis NA; Bone RC; Maunder RJ; Pullen RH; Ursprung JJ; Vassar MJ
    Am Rev Respir Dis; 1988 Jan; 137(1):5-12. PubMed ID: 3337471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostaglandin-induced hyperostosis. A case report.
    Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
    Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term prostaglandin E1 use in newborns with duct-dependent congenital heart diseases: one year experience of a tertiary neonatal intensive care unit in Turkey.
    Ustün N; Dilli D; Zenciroğlu A; Okumuş N; Cınar G; Ozgür S; Koç M
    Anadolu Kardiyol Derg; 2013 Nov; 13(7):732-4. PubMed ID: 24172809
    [No Abstract]   [Full Text] [Related]  

  • 46. Gas chromatography/negative ion chemical ionization triple quadrupole mass spectrometric determination and pharmacokinetics of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostan oic acid in plasma.
    Schweer H; Cawello W; Seyberth HW
    Prostaglandins Leukot Essent Fatty Acids; 1994 Dec; 51(6):401-5. PubMed ID: 7708804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of prostaglandin-E1 treatment on pyloric wall thickness in newborns with ductal-dependent critical congenital heart diseases.
    Tandircioglu UA; Turer OB; Soyer T; Ayaz E; Ozcan HN; Yigit S; Celik HT
    Pediatr Surg Int; 2023 Mar; 39(1):144. PubMed ID: 36856877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of PGE1 in neonatal aortic coarctation].
    Cheliakine-Chamboux C; Chantepie A; Godde F; Vaillant MC; Saliba E; Gold F; Laugier J
    Therapie; 1991; 46(3):231-3. PubMed ID: 1792657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
    Jackson EK; Goodman RP; Fitzgerald GA; Oates JA; Branch RA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):183-7. PubMed ID: 7038095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aminophylline for the prevention of apnea during prostaglandin E1 infusion.
    Lim DS; Kulik TJ; Kim DW; Charpie JR; Crowley DC; Maher KO
    Pediatrics; 2003 Jul; 112(1 Pt 1):e27-9. PubMed ID: 12837902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aneurysmal dilatation of ductus arteriosus during lipo-prostaglandin E1 therapy for diaphragmatic hernia.
    Tohyama M; Baba A; Tsuno T; Aonuma K; Komiyama A
    Eur J Pediatr; 1993 Nov; 152(11):877-9. PubMed ID: 8276014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neonatal transport issues with prostaglandin E1 infusions.
    Grubbs TC; Kraft NL
    Air Med J; 2002; 21(3):8-12. PubMed ID: 11994726
    [No Abstract]   [Full Text] [Related]  

  • 53. Echocardiographic evaluation of the ductal morphology in patients with refractoriness to lipo-prostaglandin E1 therapy.
    Takeda N; Hiraishi S; Misawa H; Agata Y; Horiguchi Y; Fujino N; Hirota H; Kawamura S; Ogawa N
    Pediatr Int; 2000 Apr; 42(2):134-8. PubMed ID: 10804727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.
    Gittenberger-de Groot AC; Moulaert AJ; Harinck E; Becker AE
    Br Heart J; 1978 Mar; 40(3):215-20. PubMed ID: 637973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of very low-dose prostaglandin E1 in duct-dependent congenital heart disease.
    Yucel IK; Cevik A; Bulut MO; Dedeoğlu R; Demir İH; Erdem A; Celebi A
    Cardiol Young; 2015 Jan; 25(1):56-62. PubMed ID: 24168719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastric outlet obstruction due to an iatrogenic cause in a neonatal period - report of two cases.
    Kosiak W; Swieton D; Fryze I; Aleszewicz-Baranowska J; Duklas M; Chojnicki M
    Ultraschall Med; 2009 Aug; 30(4):401-3. PubMed ID: 17610180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interindividual variation in the enzymatic 15-keto-reduction of 13,14-dihydro-15-keto-prostaglandin E1 in human liver and in human erythrocytes.
    Rady-Pentek P; Mueller R; Tang BK; Kalow W
    Eur J Clin Pharmacol; 1997; 52(2):147-53. PubMed ID: 9174685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Posttransplantation management of the newborn and the immunosuppressive role of prostaglandin E1.
    Assaad A
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S191-4. PubMed ID: 8312335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease.
    Kramer HH; Sommer M; Rammos S; Krogmann O
    Eur J Pediatr; 1995 Sep; 154(9):700-7. PubMed ID: 8582419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects and arterial concentration of prostaglandin E1 during cardiopulmonary bypass.
    Okuda M; Faruhashi K; Konishi K; Muneyuki M
    Eur J Anaesthesiol; 1991 Mar; 8(2):129-34. PubMed ID: 1874208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.